On 22 February 2019, the Global Fund Board approved one multi-country grant, one matching funds request and one set of interventions on the Unfunded Quality Demand (UQD) Register –– worth a total of $16.0 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). This was the 17th batch of approvals from the 2017–2019 allocations.
OIG investigation in Zambia uncovers theft of health products from national medical stores between 2014 and 2016
In an investigation of Global Fund grants to Zambia, the Office of the Inspector General (OIG) has uncovered large-scale theft of a range of HIV, tuberculosis and malaria-related medical products from Zambia’s national medical stores.
The OIG’s investigation report was made public on April 26, 2018.
African organization of ‘supreme audit institutions’ and OIG collaborate to improve grant performance and oversight
The African Organization of English-speaking Supreme Audit Institutions (AFROSAI-E) and the Global Fund’s Office of the Inspector General (OIG) signed a memorandum of understanding in February 2017 to improve the oversight over Global Fund grants implemented by state Principal Recipients (PRs), and to strengthen relationships between the OIG and the supreme audit institutions (SAIs).
A new report published by Aidspan suggests that countries may not be using data optimally to inform grant implementation. Implementers of Global Fund grants collect and use data for several different purposes, depending on the type of implementer. State Principal Recipients collect data to measure strategic impact, whereas non-state implementers appear to collect data mainly to meet reporting requirements.
Capacity issues and delays in implementation plague otherwise successful Global Fund grants to Zambia, OIG says
On 23 May 2017, Zambia submitted both TB/HIV and malaria funding requests, together worth just over $400 million. The TB/HIV funding request was for $306.8 million, of which $194.4 million constituted a within-allocation request, with a further $112.4 million as a prioritized above-allocation request (PAAR).
As reported in GFO #295, in August the Board approved $180 million in funding for 14 grants from 11 countries. The Board was acting on recommendations of the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC). This article provides a summary of the some of the comments made by the GAC in its report to the Board.
Elimination 8 (E8) has set the formidable target of full malaria elimination in Botswana, Namibia, South Africa and Swaziland by 2020. Termed the “frontline four”, these countries are nearing elimination of the disease after achieving a 75% decline between 2000 and 2012.
« Finalement, le Fonds mondial est axé sur l'être humain » : le directeur exécutif Mark Dybul présente son rapport
S'éloignant du rapport typique d'un directeur exécutif, Mark Dybul, dans le rapport qu'il a présenté au Conseil d'administration à l'occasion de la 33e réunion de celui-ci, revient sur les six déplacements qu'il a effectués au cours du premier trimestre de 2015, des voyages qui lui ont apporté la preuve de ce qu'il appelle l'ampleur et la souplesse du nouveau modèle de financement.
Switching gears from a typical executive director's report to the Board during the Global Fund's 33rd meeting on 31 March, Mark Dybul reflected on the six trips he had made in the first quarter of 2015 that demonstrated what he said were the breadth and flexibility inherent in the new funding model.